IgANEF
Description
IgANEF Tablet is a new treatment in IgA nephropathy. IgANEF tablet is a corticosteroid indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥ 1.5 g/g.
IgA nephropathy, also known as Berger’s disease, is a kidney disease that occurs when an antibody called immunoglobulin A (IgA) builds up in kidneys. This results in local inflammation that, over time, can hamper kidneys’ ability to filter waste from blood.
IgA nephropathy usually progresses slowly over years, but the course of the disease varies from person to person. Some people leak blood in their urine without developing problems, some eventually achieve complete remission and others develop end-stage kidney failure.
Each tablet of IgANEF contains enteric coated controlled release Budesonide 3mg & 9mg.